- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: bioequivalence 1) CEFPROZIL FOR ORAL SUSPENSION USP 250 mg/ 5 mL fed conditions
Total 480280 results
-
Ranbaxy Laboratories LimitedCompleted
-
Ranbaxy Laboratories LimitedCompleted
-
Ranbaxy Laboratories LimitedCompleted
-
Teva Pharmaceuticals USACompleted
-
AMAG Pharmaceuticals, Inc.TerminatedAssessing Injection Pain of Makena® (Hydroxyprogesterone Caproate Injection, 250 mg/mL) in Healthy Post-menopausal WomenUnited States
-
Teva Pharmaceuticals USACompleted
-
Eli Lilly and CompanyCompletedGlioblastoma MultiformeGermany
-
Mylan Inc.ViiV HealthcareCompleted
-
Ranbaxy Laboratories LimitedCompleted
-
Ranbaxy Laboratories LimitedCompleted
-
Sun Yat-sen UniversityGuangzhou No.12 People's Hospital; Kaiping Central HospitalUnknown
-
Teva Pharmaceuticals USACompleted
-
Teva Pharmaceuticals USACompleted
-
Aziende Chimiche Riunite Angelini Francesco S.p.ACross Research S.A.Completed
-
Aziende Chimiche Riunite Angelini Francesco S.p.ACross Research S.A.Completed
-
UCB PharmaParexelCompletedHealthy Subjects | Renal ImpairmentsJapan
-
Ranbaxy Laboratories LimitedCompleted
-
Bio-innova Co., LtdNot yet recruitingHealthy Subjects
-
SanofiCompletedDiabetes Mellitus, Type 1Belgium, France, Netherlands, Sweden
-
Regeneron PharmaceuticalsCompletedHomozygous Familial HypercholesterolemiaUnited States, Netherlands, Canada
-
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate...Completed
-
Lotus PharmaceuticalUnknownThe Objectives of the Study is to Evaluate the Efficacy and Safety of Acarmet (Metformin HCl 500 mg | Plus Acarbose 50 mg Tablets) Thrice Daily Versus Acarbose 50 mg Thrice Daily Over 16 Weeks in | Subjects With Type 2 Diabetes Mellitus.Taiwan
-
Ranbaxy Laboratories LimitedCompleted
-
Roxane LaboratoriesCompletedProphylaxis of Organ RejectionUnited States
-
Mylan Pharmaceuticals IncCompleted
-
Lexicon PharmaceuticalsCompletedRheumatoid ArthritisUnited States
-
Teva Pharmaceuticals USACompleted
-
Duke UniversityNational Heart, Lung, and Blood Institute (NHLBI); American Heart AssociationCompleted
-
Roxane LaboratoriesCompletedProphylaxis of Organ RejectionUnited States
-
Lexicon PharmaceuticalsCompletedIrritable Bowel SyndromeUnited States
-
MEDSI Clinical Hospital 1, ICURecruitingRespiratory Tract Infections | Pneumonia | Sepsis | Critical Illness | Respiratory Distress Syndrome | Pneumonia, Ventilator-Associated | Bloodstream InfectionRussian Federation
-
Bright Future Pharmaceuticals Factory O/B Bright...Chinese University of Hong KongCompleted
-
Vifor PharmaCompletedChronic Kidney DiseaseUnited States, Switzerland, Romania, Croatia, Bulgaria, Germany, Czech Republic, Poland, Russian Federation
-
Fakultas Kedokteran Universitas IndonesiaNot yet recruitingIrritable Bowel Syndrome
-
PfizerCompleted
-
Taipei Medical UniversityCompleted
-
Sirtris, a GSK CompanyGlaxoSmithKlineCompleted
-
Yuni Eka AnggrainiGadjah Mada UniversityNot yet recruiting
-
Yuhan CorporationActive, not recruitingNon-Small Cell Lung CancerHungary, Korea, Republic of, Australia, Taiwan, Serbia, Singapore, Thailand, Philippines, Turkey, Malaysia, Russian Federation, Greece, Ukraine
-
Innovative Molecules GmbHRecruiting
-
Japan Clinical Oncology GroupMinistry of Health, Labour and Welfare, JapanTerminatedA Trial of Chemotherapy Before and After Surgery for Stage II,III Esophageal Squamous Cell CarcinomaCarcinoma, Squamous Cell | Esophageal NeoplasmsJapan
-
University of ManitobainnoVactiv Inc.Completed
-
PfizerTerminated
-
University of EdinburghNHS LothianCompleted